Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey

Journal of Clinical Microbiology
Seok Hoon JeongS H Lee

Abstract

To determine the prevalence and genotypes of extended-spectrum beta-lactamases (ESBLs) among clinical isolates of Klebsiella pneumoniae and Escherichia coli, we performed antibiotic susceptibility testing, pI determination, induction testing, transconjugation, and DNA sequencing analysis. Among the 509 isolates collected from 13 university hospitals in Korea, 39.2% produced ESBLs. ESBL-producing isolates were detected in every region in Korea. A total of 44.6% of the isolates produced both TEM- and SHV-type ESBLs, and 52% of ESBL-producing isolates transferred resistance to ceftazidime by transconjugation. The ESBLs were TEM-19, TEM-20, TEM-52, SHV-2a, SHV-12, and one new variant identified for the first time in Korea, namely, TEM-116. TEM-1 and SHV-12 were by far the most common variants. TEM-1, TEM-116, and SHV-12 showed a high prevalence in K. pneumoniae. Two isolates (E. coli SH16 and K. pneumoniae SV3) produced CMY-1-like beta-lactamases, which play a decisive role in resistance to cefoxitin and cefotetan, as well as TEM-type enzymes (TEM-20 and TEM-52, respectively). Using MIC patterns and DNA sequencing analysis, we postulated a possible evolution scheme among TEM-type beta-lactamases in Korea: from TEM-1 to TEM-19, from...Continue Reading

References

Nov 11, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C C Sanders, W E Sanders
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Jan 1, 1995·The Journal of Antimicrobial Chemotherapy·S K Du BoisS G Amyes
Oct 1, 1995·Clinical Microbiology Reviews·D M Livermore
Mar 28, 1998·Antimicrobial Agents and Chemotherapy·J D PitoutC C Sanders
Jan 7, 2000·Infection·E E StobberinghJ H van Zeijl
Jul 6, 2001·The Journal of Hospital Infection·H HanbergerM Wolff
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Barry G Hall

❮ Previous
Next ❯

Citations

Apr 6, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Tzu-Lung LinJin-Town Wang
Apr 6, 2006·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Kyungwon LeeYunsop Chong
May 21, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Rumyana MarkovskaAdolf Bauernfeind
Jul 14, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Frank M AarestrupDik Mevius
Aug 10, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Samia HammamiSaida Ben Redjeb
Aug 18, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yuanyuan DongShulin Yang
May 7, 2008·Antimicrobial Agents and Chemotherapy·Joanna EmpelUNKNOWN Beta-PL Study Group
Jan 22, 2011·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Mubarak Saif AlfaresiAdeel Islam Abdulsalam
Apr 12, 2011·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Jianjun HeShunitz Tanaka
Mar 27, 2010·The Journal of General and Applied Microbiology·Marta A PoltiCarlos M Abate
Jul 28, 2009·Diagnostic Microbiology and Infectious Disease·Young Kyoung ParkKwan Soo Ko
Jul 27, 2007·International Journal of Antimicrobial Agents·Kwan Soo KoJae-Hoon Song
Apr 2, 2013·Journal of Molecular Biology·Eynat Dellus-GurDan S Tawfik
Apr 10, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN European Food Safety Authority--Working Group on Developing Harmonised Schemes for Monitoring Antimicrobial Resistance in Zo
Feb 14, 2017·The Journal of Veterinary Medical Science·Yeon Soo ChungKun Taek Park
Jul 21, 2006·Diagnostic Microbiology and Infectious Disease·Soo-Young KimKyungwon Lee
Oct 5, 2007·Diagnostic Microbiology and Infectious Disease·Emilio David Valverde RomeroJuan Luis Muñoz Bellido
Jan 4, 2017·Antimicrobial Agents and Chemotherapy·George A Jacoby, Karen Bush
Jan 4, 2017·Antimicrobial Agents and Chemotherapy·Juergen Pleiss, Catharina Zeil
Mar 6, 2009·The Korean journal of laboratory medicine·Sungwook SongSeok Hoon Jeong
Jun 19, 2012·The Korean Journal of Internal Medicine·David M Livermore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.